Respirovirus infectious disease
MONDO:0005940Infections with viruses of the genus respirovirus, family paramyxoviridae. Host cell infection occurs by adsorption, via hemagglutinin, to the cell surface.
Also known as: infections, Respirovirus
7 clinical trials for this condition and its sub-types, 0 tagged with Respirovirus infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Respirovirus infectious disease
-
1 sub-type
-
Nasal spray vaccine aims to protect kids from two breathing viruses
Vaccine CompletedThis study tested two experimental nasal spray vaccines in 24 children aged 2 to 5 years. The vaccines target two viruses that can cause breathing problems: human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3). The main goal was to see if the vaccines are safe and …
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
One shot, three viruses? new vaccine trial targets RSV, hMPV, and PIV3 in seniors
Vaccine CompletedThis Phase 1 study tests a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. The trial involves 390 adults aged 60 and older and will check if the vaccine is safe and helps the body produce antibodies. Different combinations and dose…
Phase 1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
New combo vaccine targets flu, RSV, and more in early trial
Vaccine CompletedThis early-stage study tested the safety and immune response of new vaccines that combine protection against flu, RSV, hMPV, and PIV3 in healthy adults aged 18 to 49. Participants received a single shot of one of several vaccine formulas. The goal was to see if these combination …
Phase 1 • Sponsor: Sanofi • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC